ArticleDiabetologia2024

Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study.

Arunkumar Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.